Bridgewater Advisors Inc. Invests $259,000 in Tempus AI, Inc. (NASDAQ:TEM)

Bridgewater Advisors Inc. purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,373 shares of the company's stock, valued at approximately $259,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cherry Tree Wealth Management LLC bought a new position in shares of Tempus AI in the 1st quarter valued at about $31,000. Operose Advisors LLC purchased a new stake in Tempus AI during the 4th quarter valued at about $25,000. Bartlett & CO. Wealth Management LLC grew its stake in shares of Tempus AI by 100.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after acquiring an additional 400 shares during the period. Continuum Advisory LLC purchased a new stake in shares of Tempus AI during the 1st quarter valued at about $39,000. Finally, Farther Finance Advisors LLC purchased a new position in Tempus AI during the 4th quarter worth $34,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have weighed in on TEM shares. BTIG Research started coverage on Tempus AI in a report on Monday, April 21st. They issued a "buy" rating and a $60.00 target price on the stock. Morgan Stanley raised their price target on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Guggenheim lifted their price target on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Piper Sandler increased their price target on Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th. Finally, Bank of America upped their target price on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, Tempus AI has a consensus rating of "Moderate Buy" and a consensus price target of $65.09.

Insider Activity

In other news, EVP Erik Phelps sold 51,317 shares of the stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the transaction, the executive vice president directly owned 97,779 shares in the company, valued at approximately $7,094,844.24. This represents a 34.42% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Theodore Leonsis sold 205,847 shares of Tempus AI stock in a transaction on Wednesday, June 11th. The stock was sold at an average price of $67.66, for a total value of $13,927,608.02. Following the completion of the sale, the director directly owned 15,511 shares of the company's stock, valued at approximately $1,049,474.26. The trade was a 92.99% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 612,522 shares of company stock valued at $41,600,238. Corporate insiders own 27.60% of the company's stock.

Tempus AI Price Performance

Shares of TEM opened at $60.65 on Friday. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $91.45. The firm's fifty day simple moving average is $63.06 and its 200-day simple moving average is $55.46. The firm has a market capitalization of $10.50 billion and a price-to-earnings ratio of -7.78.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The company had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The business's quarterly revenue was up 75.4% compared to the same quarter last year. Equities analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.